Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musset

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumorsM Musset, G Mathé, P Reizenstein
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumorsM Musset, G Mathé, P Reizenstein
Annales D'Urologie|January 1, 1985
[A non-secreting bladder paraganglioma. A case report]G Benoit, A Vieillefond, M Musset, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 18, 1979
[Present position of radiotherapy in the treatment of lymphomas other than Hodgkin's (author's transl)]P Benoit, M Musset, C Bersay, et al.
Chest|August 1, 1988
Pulmonary sarcoidosis associated with Leydig cell testicular neoplasmA Biglino, G Cariti, M Musset, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Relationship between proliferative activity of bone marrow micrometastasis and plasmatic level of a new cancer marker: lipid associated sialic acid (LASA) in human breast cancerM Ginsbourg, M Musset, J L Misset, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1986
Clinical characterization of imuthiolE Lemarie, M Musset, C Charbonnier, et al.
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodiesM Ginsbourg, M Musset, J L Misset, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodiesM Ginsbourg, M Musset, J L Misset, et al.
Community Dental Health|April 30, 2010
Complications following oral piercing. A study among 201 young adults in Strasbourg, FranceB M Hickey, E A Schoch, L Bigeard, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumorsM Musset, G Mathé, P Reizenstein
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumorsM Musset, G Mathé, P Reizenstein
Annales D'Urologie|January 1, 1985
[A non-secreting bladder paraganglioma. A case report]G Benoit, A Vieillefond, M Musset, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 18, 1979
[Present position of radiotherapy in the treatment of lymphomas other than Hodgkin's (author's transl)]P Benoit, M Musset, C Bersay, et al.
Chest|August 1, 1988
Pulmonary sarcoidosis associated with Leydig cell testicular neoplasmA Biglino, G Cariti, M Musset, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Relationship between proliferative activity of bone marrow micrometastasis and plasmatic level of a new cancer marker: lipid associated sialic acid (LASA) in human breast cancerM Ginsbourg, M Musset, J L Misset, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1986
Clinical characterization of imuthiolE Lemarie, M Musset, C Charbonnier, et al.
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodiesM Ginsbourg, M Musset, J L Misset, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodiesM Ginsbourg, M Musset, J L Misset, et al.
Community Dental Health|April 30, 2010
Complications following oral piercing. A study among 201 young adults in Strasbourg, FranceB M Hickey, E A Schoch, L Bigeard, et al.
Pageof 6